Renaissance Technologies
SXTP icon

Renaissance Technologies’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

Renaissance Technologies’s Portfolio SXTP Stock Details SXTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-52
Closed -$3K – 3946
2024
Q1 		$3K Buy
+52
New +$5.8K ﹤0.01% 3655

Other funds holding SXTP

CBT
Central Bank & Trust Lexington, Kentucky $705M AUM 34.21% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies's SXTP Position: Q2 2024 in Review

Renaissance Technologies sold out of 60 Degrees Pharmaceuticals (SXTP) in Q2 2024, closing a stake of 52 shares — an estimated $3K sold.

Renaissance Technologies first reported a position in SXTP in Q1 2024 and held it in 1 quarter. The position peaked at $3K in Q1 2024. 9 funds tracked by Wall St. Rank hold SXTP as of Q2 2024.

  • Renaissance Technologies reported no remaining 60 Degrees Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Renaissance Technologies sold 52 60 Degrees Pharmaceuticals shares in Q2 2024, an estimated $3K.
  • Renaissance Technologies first reported a position in 60 Degrees Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Renaissance Technologies's 60 Degrees Pharmaceuticals position peaked at $3K in Q1 2024.
  • 9 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.